A prospective, multicenter study assessing the immunogenicity and safety of the BBIBP-CorV vaccine in a cancer population
Latest Information Update: 08 Feb 2022
At a glance
- Drugs Coronavirus vaccine-Wuhan Institute of Biological Products (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions; Therapeutic Use
- 08 Feb 2022 New trial record
- 01 Jan 2022 Results published in the Cancer Investigation